Att A - Offeror Capabilities and Specimens.xlsx

XLSX spreadsheet 27 KB Posted

Attached to
CDC Multistate Assessment of SARS-CoV-2 Seroprevalence (MASS) Study
Solicitation number
RFP_75D301-20-R-68127
Issued by

About this file

This document contains a request for proposals from laboratories to provide testing services for the CDC Multistate Assessment of SARS-CoV-2 Seroprevalence (MASS) Study. Laboratories are asked to provide information on the number and demographic characteristics of specimens they can test under three task areas over periods of 1.5 to 3 months. They should also indicate whether they can provide sample results and metadata in both Excel and CSV formats. Proposals are due by September 7, 2020 and should be submitted via email. Questions from potential offerors must be submitted by August 24, 2020. The solicitation is being conducted as full and open with no set aside. The Centers for Disease Control and Prevention within the Department of Health and Human Services is the contracting agency.

View the file

Other files

File Type Posted
Att D - Question and Answer Template.xlsx XLSX spreadsheet
Att C - Pricing Table.xlsx XLSX spreadsheet
RFP 75D301-20-R-68127.pdf PDF
Att B - Task Deliverables Table.xlsx XLSX spreadsheet

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Proposal Responses

Each offeror should complete and include the below table and subsequent worksheets with their proposal.
IDQuestionAnswer
A.1How many total specimens from each US state (+ DC and Puerto Rico), stratefied by age group, do you typically accumulate over a one day period that could be used in this study?
A.2Provide aggregated, available information on the specimens referenced in Question 1 in the below worksheet tab labeled "A.3".
B.1How many total specimens from each US state (+ DC and Puerto Rico), stratefied by age group, do you typically accumulate over a two week period that could be used in this study?
B.2Provide aggregated, available information on the specimens referenced in Question 1 in the below worksheet tab labeled "B.3".
C.1How many total specimens from each US state (+ DC and Puerto Rico), stratefied by age group, do you typically accumulate over a four week period that could be used in this study?
C.2Provide aggregated, available information on the specimens referenced in Question 1 in the below worksheet tab labeled "B.3".
DWill you provide sample results and metadata information as both Excel and .CSV file types?
EHow many specimens can you test under Task Area 1 every two weeks for 3 months?
FHow many specimens can you test under Task Area 2 every two weeks for 1.5 months?
GHow many specimens can you test under Task Area 3 every two weeks for 1.5 months?

A.3

With reference to Questions A.1 in "Proposal Responses", provide any of the below information readily available:
State/ TerritoryEstimated # of available specimensAge group (0 months to ≤17 years, 18 to ≤49 years, 50 to ≤64 years, and 65+ years)% Male

B.3

With reference to Questions B.1 in "Proposal Responses", provide any of the below information readily available:
State/ TerritoryEstimated # of available specimensAge group (0 months to ≤17 years, 18 to ≤49 years, 50 to ≤64 years, and 65+ years)% Male

C.3

With reference to Questions C.1 in "Proposal Responses", provide any of the below information readily available:
State/ TerritoryEstimated # of available specimensAge group (0 months to ≤17 years, 18 to ≤49 years, 50 to ≤64 years, and 65+ years)% Male

File details come from the government source that posted it. Updated .